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Abstract 41 
Background   42 
Existing guidance for developing public health interventions does not provide information for 43 
researchers about how to work with intervention providers to co-produce and prototype the 44 
content and delivery of new interventions prior to evaluation. The ASSIST+Frank study 45 
aimed to adapt an existing effective peer-led smoking prevention intervention (ASSIST), 46 
integrating new content from the UK drug education resource Talk to Frank 47 
(www.talktofrank.com) to co-produce two new school-based peer-led drug prevention 48 
interventions. A three-stage framework was tested to adapt and develop intervention content 49 
and delivery methods in collaboration with key stakeholders to facilitate implementation. 50 
 51 
Methods 52 
The three stages of the framework were: 1) Evidence review and stakeholder consultation; 2) 53 
Co-production; 3) Prototyping. During stage 1, six focus groups, 12 consultations, five 54 
interviews, and nine observations of intervention delivery were conducted with key 55 
stakeholders (e.g. Public Health Wales [PHW] ASSIST delivery team, teachers, school 56 
students, health professionals). During stage 2, an intervention development group consisting 57 
of members of the research team and the PHW ASSIST delivery team was established to 58 
adapt existing, and co-produce new, intervention activities. In stage 3, intervention training 59 
and content were iteratively prototyped using process data on fidelity and acceptability to key 60 
stakeholders. Stages 2 and 3 took the form of an action-research process involving a series of 61 
face-to-face meetings, email exchanges, observations, and training sessions.  62 
  63 
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Results   64 
Utilising the three-stage framework, we co-produced and tested intervention content and 65 
delivery methods for the two interventions over a period of 18 months involving external 66 
partners. New and adapted intervention activities, as well as refinements in content, the 67 
format of delivery, timing and sequencing of activities, and training manuals resulted from 68 
this process. The involvement of intervention delivery staff, participants and teachers shaped 69 
the content and format of the interventions, as well as supporting rapid prototyping in context 70 
at the final stage. 71 
 72 
Conclusions 73 
This three-stage framework extends current guidance on intervention development by 74 
providing step-by-step instructions for co-producing and prototyping an intervention’s 75 
content and delivery processes prior to piloting and formal evaluation. This framework 76 
enhances existing guidance and could be transferred to co-produce and prototype other public 77 
health interventions.  78 
 79 
Trial registration: ISRCTN14415936, registered retrospectively on 05 November 2014.  80 
 81 
Keywords: intervention development; public health; co-production; prototyping; 82 
transdisciplinary action research; drug prevention; adolescence. 83 
 84 
 85 
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Background 86 
There are a range of approaches to public health intervention development [1-12]. The UK’s 87 
Medical Research Council [MRC] guidance, the most widely cited approach, recommends 88 
that intervention development should consist of theory development, identification of an 89 
evidence base (typically through a recent or new systematic review), and modelling of 90 
processes and outcomes [13]. Other approaches provide more detailed guidance on: 91 
developing intervention or program theory [2,6,9]; using mapping techniques to inform the 92 
components required in an intervention [1,5,7,10]; cycles of testing and refinement [3,8] and 93 
the use of partnerships with individuals, communities, and service providers [4,7,8,12]. These 94 
guidelines support development of a theoretical rationale for an intervention, but provide 95 
scant pragmatic instruction on how to develop intervention materials and delivery methods.  96 
 97 
Theory needs to be translated into intervention design in a way that facilitates adoption across 98 
settings and maximises implementation. The RE-AIM framework helped to re-focus away 99 
from efficacy to effectiveness, and assess the degree of reach, adoption, implementation and 100 
maintenance of effects [14]. As well as identifying reasons for (in)effectiveness, an 101 
assumption is that barriers to adoption, implementation and maintenance that are identified in 102 
evaluations are addressed in the adaptation of existing or design of new interventions. It is not 103 
clear whether this occurs. Even if barriers are addressed, as the policy and practice landscape 104 
can change with country, health system and time, some barriers identified may not be 105 
relevant in a new system. A method for the rapid identification of potential barriers to 106 
effectiveness, possible solutions, testing and re-testing of materials would save the costly 107 
implementation of interventions that do not adequately account for variations in context. The 108 
involvement of customers in the prototyping of new products has long been used in 109 
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manufacturing [15], as a method for gaining feedback and improving design. Intervention 110 
design may benefit from incorporating the principles of iterative product development and 111 
testing intervention components, or prototyping, with those who deliver and receive 112 
interventions [16].  113 
 114 
The concept of Transdisciplinary Action Research (TDAR) [12] has been developed to 115 
support effective collaboration between behavioural researchers, policy makers, frontline 116 
public services staff and communities. Building on Lewin’s [17] concept of ‘action research’ 117 
that combines scientific and societal value, TDAR is an approach where researchers from 118 
multiple disciplines work with a range of stakeholders and intended beneficiaries to jointly 119 
understand social problems and identify practical solutions to them, such as through co-120 
producing new public health interventions [5]. A key component of this approach to applied 121 
social science is the development of sustainable, replicable processes to support effective 122 
collaboration between researcher teams, frontline practitioners and communities in order to 123 
harness the latent expertise of key stakeholders (for example, those who deliver health 124 
promotion to the target population, gatekeepers within settings such as school teachers, 125 
managers, owners) so that the acceptability and feasibility of the intervention is addressed 126 
and maximised at the development stage [5, 12, 18-20].  127 
 128 
We present the framework for co-production and prototyping which was used to guide the 129 
adaptation of the ASSIST smoking prevention intervention to develop detailed content and 130 
delivery processes for two new peer-led drug prevention interventions, one as an adjunct to 131 
the ASSIST intervention (+Frank) and the other a standalone drug prevention intervention 132 
(Frank friends).  133 
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 134 
Case study: ASSIST+Frank intervention development study 135 
Informed by the principles of TDAR, we tested a novel, staged approach to adapt and co-136 
produce with stakeholders the content and delivery of two new informal, peer-led 137 
interventions to prevent illicit drug use among secondary-school students in the United 138 
Kingdom by adapting an effective peer-led smoking prevention intervention (ASSIST) [21]. 139 
ASSIST is a school-based peer-led intervention that has been shown to be effective in 140 
reducing the uptake of smoking in UK secondary schools [21]. It is recommended in the 141 
National Institute for Health and Care Excellence (NICE) guidance on school-based smoking 142 
prevention [22] and forms part of the Welsh and Scottish Governments’ tobacco harm 143 
reduction plans [23,24]. In contrast, studies of the implementation and effectiveness of peer-144 
led drug prevention interventions report mixed evidence [25-27]. For example, very low-145 
levels of implementation occurred in the EU-Dap trial, where only 8% of centres 146 
implemented all seven peer-led sessions and 71% did not conduct any meetings at all [26]. 147 
Moreover, there is some evidence of harmful effects for school students with drug using 148 
friends from the US TND-Network trial [27].  These challenges suggested new approaches 149 
were warranted and more careful intervention development was required.  150 
 151 
Informed directly by the existing evidence surrounding the effectiveness of the ASSIST 152 
intervention [21] and its basis in the theory of Diffusion of Innovations [28], we adapted the 153 
ASSIST model of informal peer-led delivery (see Table S1 in Additional file 1 for 154 
components of ASSIST) to drug prevention using information from the UK national drug 155 
education website, Talk to Frank
 
[29]. The theoretical basis and design of the effective 156 
ASSIST informed a skeleton structure of core intervention components and processes that 157 
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underpinned the development of the two new informal, peer-led interventions to prevent 158 
illicit drug use. From this, an intervention logic model was constructed for each of the two 159 
new peer-led drug prevention interventions, +Frank and Frank friends (see Additional file 1: 160 
Figures S1 and S2), which would be compared at subsequent stages of evaluation.  161 
 162 
The intervention “+Frank” is as an informal peer-led drug prevention adjunct to the ASSIST 163 
smoking prevention intervention. It is designed to be delivered in secondary schools to year 9 164 
students (aged 13-14) who have previously received ASSIST in year 8. Frank friends is a 165 
stand-alone, informal drug prevention intervention. It aims to identify and recruit peer 166 
opinion leaders in year 9 to be trained as peer supporters. Both interventions involve off-site 167 
training to learn the effects and risk associated with specific drugs and potential harms; 168 
+Frank involves one day and Frank friends two days of training. Peer supporters are asked to 169 
have conversations with their peers on the risks of different drugs and log these interactions 170 
over 10-weeks. +Frank peer supporters are visited three times and Frank friends four times by 171 
trainers to support them have conversations. 172 
 173 
Methods 174 
A three stage multi-method framework was tested to co-produce the content, resources, and 175 
delivery methods for the +Frank and Frank friends interventions based on their logic models. 176 
The three stages are: 1) Evidence review and stakeholder consultation; 2) Co-production; and 177 
3) Prototyping. The methods used at each stage allowed for integration of scientific literature 178 
with stakeholders’ knowledge and expertise. The key stakeholders in intervention 179 
development were the Public Health Wales (PHW) ASSIST delivery team, secondary school 180 
students, and health professionals working for drug agencies and with young people. The 181 
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objectives of the methods used and topics explored at each stage/stage are summarised in 182 
Table S2 (Additional file 1). 183 
 184 
Stage one: Evidence review and stakeholder consultation 185 
In stage one, ‘evidence review and stakeholder consultation’, members of the research team 186 
engaged in a process of co-operative enquiry with stakeholders. A variety of consultation 187 
methods were offered to groups of stakeholders to enable them to participate in the way that 188 
they felt was most appropriate. The overall aim of the stakeholder consultation was to gather 189 
multiple perspectives about drug use issues relevant to young people, existing drug education 190 
for young people, and ideas for appropriate and acceptable content for the peer-led drug 191 
interventions. This involved a range of methods. 192 
 193 
Focus groups with young people. Six focus groups were conducted with 47 young people 194 
aged 13-15 who were purposively sampled from a range  of settings allowing for variation in 195 
demographic backgrounds and existing experience of drug use (three schools, a youth centre 196 
and a student referral unit). A semi-structured topic guide was used consisting of broad open-197 
ended questions relating to participatory task-based activities using information and resources 198 
from Talk to Frank. 199 
 200 
Interviews with the ASSIST intervention delivery team. Interviews were conducted with an 201 
opportunity sample of five members of the PHW ASSIST delivery team.  202 
 203 
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Observations of current practice. Observations of all five stages of ASSIST intervention 204 
delivery were conducted (n=8) as well as one observation of the ASSIST ‘Train the Trainers’ 205 
course.  206 
 207 
Stakeholder consultation. A range of unstructured consultations were also conducted with 208 
opportunity samples of young people and practitioners: one with five volunteers from a 209 
young people’s public involvement group [ALPHA] aged 16-19 years old; one with seven 210 
young people aged 13-15; one with five recipients of ASSIST aged 12-13; and nine 211 
individual consultations with health professionals working for drug agencies (n=4) or with 212 
young people (n=4) or both (n=1).   213 
 214 
Audio recordings of the focus groups and interviews were transcribed verbatim and analysed 215 
using thematic analysis. An a priori coding framework focused on the objectives of the 216 
interviews with the delivery team was applied to the interview transcripts to organise data for 217 
subsequent searches for recurring patterns and themes. However, an element of flexibility 218 
was maintained such that codes which did not fit the framework were also captured. This 219 
analysis approach has been described in detail elsewhere [30].  220 
 221 
Researcher field notes from observations and informal consultations were collated and 222 
combined with the outcomes from the analysis of interview and focus group data in order to 223 
identify similarities and differences across the various stakeholder perspectives emerging 224 
from the consultation process. These outcomes were then taken forward to feed into the co-225 
production of intervention content during stage 2.   226 
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  227 
Stage two: Co-production 228 
In stage 2, ‘co-production’, an intervention development group consisting of members of the 229 
research team and key stakeholders was established to co-produce the intervention materials 230 
and resources. The key stakeholders identified for adapting the ASSIST intervention to 231 
deliver information from Frank were members of the Public Health Wales [PHW] ASSIST 232 
delivery team. The PHW team had delivered ASSIST to over 350 schools over a period of 233 
seven years so had extensive experience of intervention delivery within schools and were 234 
well placed to consider the potential feasibility of adapting intervention content for use with 235 
an older age group and for drug prevention.  The team had also been identified to deliver the 236 
new drug prevention interventions that were being developed.  237 
 238 
Co-production of intervention content took the form of an action research cycle over a series 239 
of meetings of the intervention development group in which findings from stage 1 were 240 
considered, ideas were presented by all members, feedback on ideas sought, refinements 241 
made and presented again, until final content was agreed. Five face-to-face meetings were 242 
held over the course of a four month period. These were supplemented by communications 243 
via email where face-to-face meetings were not possible, or when matters arose that required 244 
discussion between meetings.  245 
 246 
Stage three: Prototyping 247 
In stage 3, ‘prototyping’, the draft intervention manuals and associated resources underwent 248 
expert review by the lead author of the ASSIST randomised controlled trial [21], and the lead 249 
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trainer of DECIPHer Impact, the company that licenses ASSIST. Reviewers looked over the 250 
adaptations made to ASSIST intervention content and resources, as well as newly developed 251 
content, and were asked to provide feedback regarding key uncertainties identified during 252 
development (for example, fit with the diffusion of innovations theory,  age-appropriateness 253 
of activities, suitability of timings and sequencing). 254 
 255 
In order to gain preliminary feedback regarding acceptability and feasibility of the 256 
intervention content, intervention delivery was tested with an opportunity sample of the 257 
ALPHA group (n=5), as well as during two training sessions with the intervention delivery 258 
team. Independent observations of intervention delivery in two test schools were made by 259 
two members of the research team using a structured observation tool to check whether the 260 
learning outcomes for each activity were met and any deviations that were made.  261 
 262 
Results 263 
Figure 1 shows the framework and activities that were completed in the ASSIST+Frank 264 
intervention development study stage. The process of co-production and prototyping took 18 265 
months comprised 42 activities (Figure S3 shows the frequency and time line of each 266 
activity). The process was iterative and cumulative with refinements occurring prior to the 267 
next stage.    268 
 269 
Stage one: Evidence review and stakeholder consultation 270 
In line with the MRC guidance on developing complex interventions [13], we reviewed the 271 
existing literature to identify the existing distribution of illegal drug use amongst young 272 
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people and whether there were any existing effective school-based drug prevention 273 
interventions. A non-systematic review of population-based prevalence studies with 274 
secondary school-aged children in the United Kingdom (aged 11 to 16 years of age) showed 275 
the lifetime prevalence of any illegal drug use doubled from 6.8% to 12.4% then 23.1% 276 
between the ages of 13, 14, and 15 years respectively [31], this informed our decision to 277 
deliver the intervention to UK year 9 students (13 to 14 years of age) as it an age of rapidly 278 
increasing drug experimentation. A systematic review of school-based drug prevention found 279 
small effects on cannabis use in the short term and poor implementation of interventions that 280 
were peer delivered [25, 26]. The development of the +Frank and Frank friends interventions 281 
was informed by the effectiveness of the ASSIST intervention [21] and its basis in the theory 282 
of Diffusion of Innovations [28], an approach not previously used in relation to youth drug 283 
prevention.  284 
 285 
During stage one we consulted with key stakeholders with the aim of gathering information 286 
to tailor the interventions to the target context and population in order to maximise 287 
acceptability and reduce problems with implementation. Key stakeholders were identified as 288 
people with direct experience or knowledge of youth drug taking, recipients of the existing 289 
ASSIST smoking prevention intervention, intended recipients of the newly developed 290 
interventions, and those who delivered any existing drug prevention interventions within the 291 
setting (i.e. schools) or provided intervention resources (e.g. financing, staffing).  292 
 293 
Table 1 summarises the results from the stage one focus groups, interviews, consultations and 294 
observations. Several narratives were replicated across the different stakeholders. With regard 295 
to which drugs the intervention should prioritise, the young people aged 12-18, practitioners 296 
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working in drug support agencies with young people, and the review of prevalence studies all 297 
highlighted the same eight drugs which had over a 1% prevalence in 13-15 year olds [31]. 298 
The consultations with young people and practitioners also noted a local issue with steroid 299 
use in older age groups, which was not apparent in prevalence data as these were gathered in 300 
England and did not sample from Welsh schools. These consultations led us to tailor the 301 
intervention to the local context by including information on steroids in the interventions.  302 
 303 
[insert Table 1 here] 304 
 305 
The consultations and focus groups with young people suggested that 13 to 14 year olds were 306 
relatively familiar with the potentially harmful effects of drugs on health.  307 
“Like we all know weed is bad, we all know what it does to you as well.” [P1, male] 308 
 309 
Young people were less familiar with the potential legal consequences of being caught in 310 
possession of an illegal drug in the UK.  311 
“When it says unlimited fine, does that mean the police can just charge you?” [P2, 312 
female]  313 
 314 
The familiarity of young people with the harms of drugs on health, prompted us to also add 315 
focus on the harms associated with drugs being illegal and therefore unregulated, such as 316 
unexpected effects brought about by consuming an unknown compound of an unknown dose. 317 
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Other concerns that young people voiced included the potential harms of drug use on family 318 
relationships, future education and employment.   319 
“I mean that’s your mum, that’s one of your parents, they put a roof over your head. 320 
If you get drove away from them you don’t get food for yourself, you don’t get a roof 321 
over your head, you’re out on the streets. You don’t have anyone to get you a meal or 322 
look after you ‘cause you’re on your own.” [P3, male] 323 
 324 
“‘Cause then you’re getting a criminal record that’s stopping you from getting a job 325 
and loads of stuff.” [P4, female] 326 
 327 
A number of factors that might influence the engagement of students during peer supporter 328 
training were found in both the interviews with the ASSIST delivery team and independent 329 
observations by the research team of delivery of the intervention. In particular, the 330 
importance of flexibility in delivery of intervention activities to different groups and the need 331 
for engaging, interactive content. 332 
“We work to the same objectives, but in terms of how we run some activities, we 333 
might change them a bit … with different groups you know, how they react to a 334 
certain activity you might change it round to help the running of it.” [T1] 335 
 336 
“I think it’s important that whatever we do that it’s quite engaging and [students] get 337 
an input as well, you know, not just sitting there watching us, listening to us, I think 338 
it’s important that it’s interactive as well.” [T3] 339 
 340 
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“Making sure that they’re interactive … so they’re up and about, they get moving 341 
around, break off activities, um, just making it as interactive as possible.” [T4]  342 
 343 
Stage two: Co-production  344 
During the co-production process, the intervention development group reflected on findings 345 
from stage one and used these to inform the adaptation of content from ASSIST and the 346 
development of new content. The group was participatory and collaborative and all members 347 
were provided with opportunities to input. This process exploited the intervention delivery 348 
team’s experience with the setting, target population, and intervention content. For example, 349 
it was noted during the stage 1 interviews with the ASSIST team that an important aspect of 350 
the intervention for them was providing the peer supporters with interesting and memorable 351 
facts about smoking that they could use in conversations with their peers.  352 
“There’s key facts within ASSIST … four thousand chemicals [in a cigarette], um, 353 
sixty to seventy chemicals cause cancer, and we always get the impotence one as well. 354 
So the boys always remember the erectile dysfunction.” [T3] 355 
 356 
“So if we can give them facts that sort of link into what they could be talking about 357 
with their friends, it makes it easier for these conversations to happen. In ASSIST, one 358 
of the facts they always remember, is that smoking could affect your ability to get an 359 
erection. That is the one that sticks with them, and you might not have done the 360 
training for ten weeks, and they will still remember that.” [T1] 361 
 362 
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“In ASSIST, we know that young people will leave knowing the ingredients of a 363 
cigarette, long-term, short-term health effects, is it guaranteed. We know that you'd 364 
go up to any young person that had done the training and you'd ask them how many 365 
ingredients are in a cigarette and they’d be able to tell you.” [T1] 366 
 367 
This was also observed in field notes of the observations of delivery of the ASSIST 368 
intervention made by the research team. During stage two, the intervention development 369 
group considered these findings and decided to adapt information from the Talk to Frank 370 
website [29] about the risks of drug use into memorable factual statements. These key 371 
statements were then used across several activities within the peer supporter training and 372 
added to the peer supporter diaries as a reminder. Examples of the statements include; 373 
“Cannabis contains some of the same chemicals as tobacco”, “A drugs-related conviction can 374 
stop you from travelling to some countries, such as the USA” and “Giving cannabis to your 375 
mates is considered ‘supplying’ under the law”.  376 
 377 
Both the research and ASSIST teams independently developed adaptations and new content 378 
which were shared amongst the group. For example, a member of the ASSIST team had 379 
already developed a new mode of delivery for one of the training day activities in ASSIST in 380 
order to address an existing feasibility issue. This was incorporated into the adapted activity 381 
for the new interventions.  382 
 383 
Stage three: Prototyping 384 
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A period of prototyping of the intervention content, materials and delivery methods is a 385 
necessary next step for identifying early issues with acceptability, feasibility and other 386 
potential teething problems so that these can be addressed prior to formal piloting and 387 
evaluation.  388 
 389 
Expert peer review of intervention content or components is useful for examining key 390 
uncertainties that have been identified during development. Expert reviewers should be 391 
selected based on the areas of greatest of uncertainty and be independent of the intervention 392 
development group. There were two areas of uncertainty identified during the development of 393 
+Frank and Frank friends; how newly developed activities fit with the diffusion of 394 
innovations theory, and whether the format of activities was age-appropriate and followed 395 
suitable timings and sequencing.  396 
 397 
We sought expert feedback from the lead author of the ASSIST RCT [21] to examine fit with 398 
theory and from the lead trainer at DECIPHer Impact who delivers all training to new 399 
ASSIST teams to advise on timings and sequencing. The feedback received included possible 400 
minor refinements to the timing of some intervention activities and the presentation of 401 
instructions in the intervention manual. In addition it was suggested that consideration was 402 
given to ‘future proofing’ intervention resources by identifying content that may require 403 
regular review and updating.   404 
 405 
Testing delivery of the draft intervention content or components on a small scale is also 406 
recommended. Where possible the intervention should be delivered to a sample of the target 407 
population, if not it is advisable to make use of opportunities for simulated delivery. During 408 
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testing, data should be collected to explore the experiences of those delivering the 409 
intervention as well as those receiving it in order to inform refinements.  410 
 411 
Table 2 shows an example of how intervention content was co-produced over each stage of 412 
the framework, including how the iterative process of gathering feedback and making 413 
refinements was made during the prototyping stage in response to delivery of an activity from 414 
the peer supporter training. The objective of the activity (titled ‘What is a drug?’) is to define, 415 
name and categorise the effects of drugs. A series of insights were generated from testing out 416 
delivery with a group of young people, as well as during training of the intervention delivery 417 
team, where the trainees practised delivery of intervention activities with each other. Without 418 
this period of testing, these issues would not have emerged until formal piloting. These 419 
included: trainers being anxious they would have to have an encyclopaedic knowledge about 420 
drugs after young people generated over thirty names of drugs in the test phase; 421 
underestimating the time taken to list drugs during the activity; and confusions over drugs 422 
with a dual effect. Refinements were made to the training manuals and activities were 423 
amended to address these findings and the content was tested again.  424 
 425 
[insert Table 2 here] 426 
 427 
Reflections on co-production  428 
Interviews with the ASSIST team at the end of stage three suggested they believed co-429 
production created a sense of ownership and buy-in of the intervention, which they were 430 
going to be delivering as part of the study: 431 
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‘Oh I really enjoyed it, I think it was very beneficial, especially because if, we’re the 432 
ones that’ll be ending up delivering it’ [T1] 433 
 434 
‘It’s good that you know, I can say that I’ve kind of contributed towards developing 435 
something new’ [T2] 436 
 437 
‘. . . The team appreciate being asked as well because you know in the future if we are 438 
expected to deliver, knowing that we’ve been part of it from the start really does help’ 439 
[T4] 440 
 441 
Throughout co-production the intervention delivery team had been able to convey the 442 
realities of delivering interventions to young people and had highlighted important potential 443 
barriers to implementation which were addressed at an early stage.  444 
‘I think it’s helped to have us involved, just because we’ve got the hands-on 445 
experience of working with young people’ [T5] 446 
 447 
Independent observations by the research team of delivery of the finalised intervention 448 
identified that some trainers continued to adapt activities during delivery, after co-production 449 
had ended. In the +Frank intervention, across the 15 activities, five were delivered in full, 450 
eight had minor deviations from the manual and two were not delivered at all. In the Frank 451 
friends intervention, across the 25 activities, 13 were delivered in full, nine had minor 452 
deviations and three were not delivered at all. Field notes suggested the delivery team 453 
struggled to switch off from an intervention development mind-set even after co-production 454 
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had ended. If carried through to formal piloting, the interventions may not be delivered 455 
entirely as intended which may potentially be a barrier to implementation with high fidelity.  456 
 457 
Discussion 458 
The three-stage framework presented extends current guidance by providing pragmatic 459 
guidance on how to co-produce and prototype public health intervention content and delivery 460 
methods before formal piloting. It provides a framework to guide co-production with 461 
stakeholders so that intervention content is tailored to the population and setting in order to 462 
address implementation issues at the design stage. This is complementary to existing 463 
intervention development guidelines which provide information about the use of mapping 464 
techniques [1,5,7,10], intervention theory development [2,6,9] and testing [3,8]. Our 465 
framework offers insight into how collaboration and co-production with stakeholders can be 466 
incorporated into these stages of intervention development.  467 
 468 
The incorporation of stages of co-production and prototyping builds on existing literature on 469 
Transdisciplinary Action Research [5, 12] as well as theories of capacity building noted in 470 
community psychology [32], participatory action-research [33], plan-act-study-do cycles in 471 
clinical settings [34, 35], and the use of quality improvement replications to improve systems 472 
[36]. The involvement of key stakeholders in the co-production of intervention content 473 
provides a mechanism for tailoring intervention content to the context and target population 474 
to maximise acceptability and reduce the likelihood of problems with implementation. A 475 
variety of stakeholders should be engaged to ensure that a range of expertise and perspectives 476 
relevant to the realities of the intervention problem, target population, and intended delivery 477 
setting is represented.   478 
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 479 
The case study presented here provides an example of co-production with key stakeholders 480 
throughout the lifecycle of intervention development to adapt content from an existing 481 
effective peer-led smoking prevention intervention to co-produce two new peer-led drug 482 
prevention interventions. Based on this experience we offer some reflections on the benefits 483 
and potential weaknesses of such an approach.  484 
 485 
Benefits of co-production 486 
The involvement of stakeholders with knowledge and experience of existing interventions, 487 
the target population, and the delivery setting has the purpose of maximising the 488 
acceptability, feasibility and quality of the intervention being developed and its fit with the 489 
implementation context. For example, frontline practitioners know the delivery setting, as 490 
well as issues that have affected the implementation of previous interventions. In addition, 491 
co-production engenders an element of ‘buy-in’ to the intervention and creates a sense of 492 
ownership amongst those involved in its development. This can be particularly useful where 493 
the intended intervention deliverers can be identified at the development stage and invited to 494 
be involved in the intervention development process. In addition, the involvement of the 495 
intended intervention recipients during co-production can help to ensure that intervention 496 
content meets their needs and is acceptable and credible.   497 
 498 
Weaknesses of co-production 499 
The co-production process is both iterative and fluid. However, there must come a stage in 500 
the process where intervention content is consolidated and put to the test. Observations of 501 
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delivery found that some staff made amendments to activities, after it was agreed that co-502 
production had ended and the intervention manual finalised. This meant that out of 40 503 
activities 17 (42.5%) were delivered with a minor deviation from the instructions in the 504 
manual and five (12.5%) were not delivered at all. This suggests it may be difficult for 505 
stakeholders to demarcate when the co-production process has ended, which may be a threat 506 
to fidelity if carried through to formal delivery outside of piloting.  507 
 508 
There are several potential barriers to co-production including competing priorities and goals 509 
and interdisciplinary conflict between the stakeholders involved in the intervention 510 
development process. This is more likely when the stakeholders involved are from a range of 511 
background fields, bridging both professional and lay perspectives [12]. Another potential 512 
barrier is the time consuming nature of co-production which requires active engagement from 513 
those involved over an indeterminate amount of time to allow the process to unfold and 514 
evolve. Some stakeholders may not have the flexibility within their roles that the PHW 515 
ASSIST team had so may not be so heavily involved. There may be some potential limits to 516 
the transferability of this approach for the development of other public health interventions. 517 
The framework was used to adapt an existing intervention with a strong evidence base and a 518 
well-established delivery structure. In addition, the PHW ASSIST team were highly 519 
experienced in terms of knowledge and delivery of ASSIST to the target population. These 520 
conditions may have contributed to the successful application of the framework within this 521 
study.  522 
      523 
Conclusions 524 
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The framework presented here provides pragmatic instruction on how to coproduce and 525 
prototype public health interventions. It complements other intervention development 526 
guidance by providing more detail on the process of the early stages of intervention 527 
development and co-production that receives limited attention in existing guidance on 528 
intervention development [1-12]. Future studies should explore its utility in guiding the 529 
process of co-production of interventions with different target behaviours, populations and 530 
stakeholder groups.  531 
 532 
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a
 Stakeholders comprise those within or external to the delivery setting (e.g. school-based: school 592 
teachers, head teacher, contact teacher, head of Personal, Social, Health and Economic (PSHE) 593 
education, head of year, receptionist; national and local policy leads; parents/ guardians/ caregivers). 594 
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Table 1. Results from application of the 3-stage framework for co-production and prototyping in the ASSIST+Frank study 
Activity  Objectives Results 
Stage 1: Evidence review and stakeholder consultation 
Evidence review Identify target age group for 
interventions and identify target drugs 
to focus intervention content on.  
 The Smoking, Drinking and Drug Use survey in Young People 
showed the use of any drug in the last year almost doubled from 6.8% 
at age 13, to 12.4% at age 14, and then again to 23.7% at age 15; 
largely due to increases in the use of cannabis [31]; 
 Target intervention at 13-14 year olds (Year 9 students); 
 Focus intervention content on drugs with >1% prevalence in 13-15 
year olds (cannabis, volatile substances, ecstasy, poppers, cocaine, 
ketamine, mephedrone, and magic mushrooms). 
Consultation with young 
people’s involvement group 
Explore thoughts about drug education 
in school, their conversations about 
drugs with friends, awareness of Talk 
to Frank and opinions of the website.  
 Drug education is typically didactic and should be more interactive; 
 Discussions with peers about drugs are frequent;  
 Commonly used drugs at their age are alcohol, cannabis, poppers, 
mephedrone, ketamine and cocaine;  
 Talk to Frank was viewed positively, but should be accompanied by 
other visual resources.  
Consultation with Year 9 
students 
Explore views about drug use in their 
age group and ideas about content for 
a drug prevention intervention. 
 Content suggested included effects of drugs on the body, and the legal 
consequences of drug possession;  
 Specific drugs to focus content on included cannabis, alcohol, 
steroids, magic mushrooms and legal highs.  
Focus groups with Year 9 
students 
Explore knowledge and risk 
perceptions of drug use and 
perceptions of drug use prevalence in 
their age group. Explore acceptability 
and age-appropriateness of drug 
 Health risks of cannabis are known;  
 Legal consequences of cannabis use are less well known; 
 Content on impact of drug use on educational achievement directly, or 
through school exclusions if caught in possession needed; 
 Content on impact of drug use on parents worrying about harms (to 
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education messages on Talk to Frank 
website. 
health, criminal sanctions, schooling exclusions), shame brought to 
family, and increasing stress would be welcomed; 
 Attention to potential iatrogenic effect of Talk to Frank messages on 
amphetamine use promoting weight loss required. 
Consultations with 
stakeholders (Drug agencies 
and professionals who work 
with young people) 
Explore awareness of drug education 
resources and support, and views on 
appropriate content for a drug 
prevention intervention. 
 Cannabis and alcohol are the most commonly used drugs by 13 to 14 
year olds;  
 New Psychoactive Substances (NPS) are an increasing concern, 
particularly synthetic cannabinoids; but not in 13 to 14 year olds;  
 Staff from drug agencies noted a local problem with anabolic steroids 
regarding attendance at needle exchange programs. Use is not in 13-
14 year olds;  
 Existing drug education for 13-14 year olds is either provided in 
classroom-based sessions, or one-off workshops delivered by a 
specialist agency or a community police officer;  
 There are limited drug education resources available and existing 
resources such as ‘drugs box displays’ are expensive. Resources 
require regular updates in response to emerging NPS and changing 
trends. 
Consultations with Year 8 
recipients of ASSIST 
Explore ideas about peer supporter 
training and content for a drug 
prevention intervention.  
 Content suggested included effects of drugs on the body, how drugs 
cause ‘highs’, health risks, legal consequences, and harm 
minimisation;  
 Specific drugs to focus content on included cannabis, solvents, magic 
mushrooms, cocaine, speed, mephedrone, legal highs, and steroids.  
Observations of current  
ASSIST practice 
Identify aspects of the intervention that 
work well and could be adapted for 
use to deliver a drug prevention 
intervention and with a Year 9 
population.  
 Flexibility in adapting timings and delivery modes to respond to 
student engagement is key for successful delivery of training;  
 Need for clear objectives noting which are essential to deliver.  
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Interviews with intervention 
delivery team 
Identify possible influences on 
intervention feasibility and 
acceptability. For example, explore 
aspects of ASSIST that could be 
adapted for use to deliver a drug 
education intervention and for use with 
13-14 year olds, as well as those which 
might not lend themselves to 
adaptation.  
 Intervention activities need to be interactive;  
 Successful implementation of intervention requires flexibility in 
delivery to meet needs of different groups;  
 Some intervention activities required updating (e.g. ASSIST activity 
using postcards because peers supporters did not know what they 
were);  
 Some intervention activities might be too immature for use with 13-
14 year olds;  
 Delivery of messages about harms of drug use is much more complex 
than harms of smoking (more compounds with different effects);  
 Concerns around amount of knowledge required to deliver drug 
prevention intervention.    
Stage 2: Co-production 
Meetings of the intervention 
development group 
Action research cycle of assessment, 
analysis, feedback and agreement on 
the core components of the 
intervention required to educate peer 
supporters on the harms of drug use 
and the skills required to communicate 
these to their peers.  
 Findings from Stage 1 suggested long-term harms to health of low-
levels of cannabis are less definitive than those of smoking;  
 Include content on concerns expressed by young people and harms 
associated with drug use that they did not know about;  
 Shift focus towards these concerns and away from harms to health of 
the most commonly used drug - cannabis; 
 Highlight the potential immediate harms to health from use of glues, 
gasses and aerosol (i.e. sudden sniffing death); 
 Harms associated with drugs being unregulated and illegal: unknown 
compound and dose, thus unexpected effects are likely; 
 Potential consequences of sanctions imposed by schools (temporary, 
permanent exclusion) and poorer educational achievement; 
 Potential consequences of criminal sanctions on travel and future 
career options;  
 Mention harms including increasing parental anxiety, stress and 
shame; 
 Draft intervention manuals and associated resources detailing 
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intervention activities and how these should be delivered were 
produced. 
Stage 3: Prototyping  
Expert review of 
intervention materials 
Identify potential problems or 
weaknesses in intervention materials 
prior to piloting.  
 Updating of some intervention activities was welcomed;  
 More detail needed in instructions for delivery team;  
 Refining of timings for some intervention activities.  
Testing of intervention 
materials with young people 
Delivery of intervention. Identification 
of issues around feasibility and 
acceptability of newly developed 
intervention content.  
 Intervention activities were well received;  
 Refinements included amending wording, providing more detailed 
instruction and objectives, and using smaller groups. 
Training of intervention 
delivery team 
Simulation of intervention delivery. 
Identify issues around feasibility and 
acceptability of intervention content.  
 Need for additional drug education training;  
 Refinements included amending timings, clarifying ambiguities in 
instructions, changing format of delivery, adding extra content and 
removing content.  
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Table 2. Example of co-production and prototyping of intervention content in 
ASSIST+Frank 
Stage two: Co-production    
Initial activity description: What is a drug? 
A new activity was initially drafted by the research team to assess peer supporters’ existing 
knowledge about drugs, awareness of compounds associated with street names and their 
effect on the body. After presenting the activity at a meeting of the intervention development 
group, the Public Health Wales delivery team suggested that peer supporters be instructed to 
produce a list of all of the drugs that they had heard of on individual sticky notes. Trainers 
would then worked with students to categorise these drugs as stimulants, depressants, 
hallucinogens, or opiates.  
 
Stage three: Prototyping  
Results from the first training session 
During the first training session, the ASSIST trainers were concerned that they would need an 
encyclopaedic knowledge about drugs to deliver the activity. They noted that their knowledge 
of drugs would be insufficient due to the variety of drug types covered, street names across 
different localities, new drugs becoming available and the dual effects of drugs. 
 
Activity amendments 
Training: We provided an additional drug education session, covering the drugs associated 
with street names, appearance and effects of drugs. A booklet from Talk to Frank [25] was 
provided to all trainers covering street names, appearance and effects of the most prevalent 
drugs.  
 
Activity: Drug names generated by peer supporters which were new to trainers were listed on 
a separate sheet. Trainers emphasised the difficulty of keeping track of new drugs and street 
names and suggested students visit the Talk to Frank website for this information;  
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Instead of categorising all drugs listed, the categorisation task was limited to the ten most 
prevalent in 13-14 year olds as identified in the evidence review;  
Information cards with the drug name, common street names, appearance and effects for the 
ten most prevalent drugs were provided to trainers. 
Results from practice of delivery in the second training session 
Trainers’ confidence had improved but there was confusion about how to categorise a drug 
which had a dual effect (e.g. dose specific effects of ketamine mean that at low doses it acts 
as a hallucinogen and at high doses as a depressant). Categorisation also took longer than 
expected.  
 
Activity amendments 
To categorise drugs according to only their main effect. Opiates were removed as a category 
to reduce the time spent on the activity, as the latest prevalence data consulted in the stage 1 
evidence review suggested only 0.1% in 13 year olds and 0.2% in 14 year olds had used 
opiates in the past year [31].  
 
